Comparison between C-reactive protein and adipocyte fatty acid-binding protein as a component of metabolic syndrome in middle-aged women

Clinical Biochemistry

Volumn 44, Issue 4, 2011, Pages 304-306

  Stefanska, Anna ^a   Sypniewska, Grazyna ^a   Blaszkiewicz, Beata ^a   Ponikowska, Irena ^a   Cwiklinska Jurkowska, Malgorzata ^b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Adipocyte fatty acid binding protein; C reactive protein; Metabolic syndrome

Indexed keywords

C REACTIVE PROTEIN; FATTY ACID BINDING PROTEIN;

AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ADIPOCYTES; ADULT; AREA UNDER CURVE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; INSULIN RESISTANCE; LOGISTIC MODELS; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; POLAND;

EID: 79651471425     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.12.002     Document Type: Article

References (10)

1. Bo S., Gentile L., Ciccone G., Baldi C., Benini L., Dusio F., et al. The metabolic syndrome and high C-reactive protein: prevalence and differences by sex in a southern-European population-based cohort. Diab Metab Res Rev 2005, 21:515-524.
2. Stejskal D., Karpisek M. Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome?. Eur J Clin Investig 2006, 36:621-625.
3. Xu A., Wang Y., Xu J.Y., Stejskal D., Tam S., Zhang J., et al. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 2006, 52:405-413.
4. Han T.S., Sattar N., Williams K., Gonzalez-Villalpando C., Lean M.E., Haffner S.M. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diab Care 2002, 25:2016-2021.
5. Ridker P.M., Wilson P.W., Grundy S.M. Should c-reactive protein be added to metabolic syndrome and to assessment of Global Cardiovascular Risk?. Circulation 2004, 109:2818-2825.
6. Tso A.W., Xu A., Sham P.C., Wat N.M., Wang Y., Fong C.H., et al. Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diab Care 2007, 30:2667-2672.
7. Kahn S.E., Zinman B., Haffner S.M., O'Neill M.C., Kravitz B.G., Yu D., et al. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes 2006, 55:2357-2364.
8. Aronson D., Bartha P., Zinder O., Kerner A., Markiewicz W., Avizohar O., et al. Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome. Int J Obes Relat Metab Disord 2004, 28:674-679.
9. Devaraj S., Swarbrick M.M., Singh U., Adams-Huet B., Havel P.J., Jialal I. CRP and adiponectin and its oligomers in the metabolic syndrome: evaluation of new laboratory-based biomarkers. Am J Clin Pathol 2008, 129:815-822.
10. Oda E., Kawai R. Comparison between high-sensitivity C-reactive protein (hs-CRP) and white blood cell count (WBC) as an inflammatory component of metabolic syndrome in Japanese. Intern Med 2010, 49:117-124.